Abstract
Sentinel lymph node (SLN) biopsy is a standard of care for axillary staging in breast cancer. The modalities involving radioisotope (RI) and blue dye are the most widely used for SLN mapping. Near-infrared fluorescence imaging using indocyanine green (ICG) visualizes superficial lymphatic flow from tumor to SLN transcutaneously and directs the surgeon to the tumor-draining SLN in the axillary basin. This novel method achieves a high detection of SLN comparable with the RI method, and the additional use of ICG fluorescence maximizes the detection impact of RI. The ICG fluorescence method is reliable and safe and would be an acceptable alternative to SLN mapping using radioactive tracers in early breast cancer.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Halsted CP, Benson JR, Jatoi I (2014) A historical account of breast cancer surgery: beware of local recurrence but be not radical. Future Oncol 10(9):1649–1657
Morton DL, Wen DR, Wong JH et al (1992) Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127:392–399
Krag DN, Weaver DL, Alex JC, Fairbank JT (1993) Surgical resection and radiolocalization of the sentinel node in breast cancer using a gamma probe. Surg Oncol 2:335–339
Giuliano AE, Kirgan DM, Kuenther JM, Morton DL (1994) Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220:398–401
Kim T, Giuliano AE, Lyman GH (2006) Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma. Cancer 106:4–16
Morrow M, Rademaker AW, Bethke KP et al (1999) Learning sentinel node biopsy: results of a prospective randomized trial of two techniques. Surgery 126:714–720
Kitai T, Inomoto T, Miwa M, Shikayama T (2005) Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer. Breast Cancer 12:211–215
Yamauchi K, Nagafuji H, Nakamura T et al (2011) Feasibility of ICG fluorescence-guided sentinel node biopsy in animal models using the HyperEye Medical System. Ann Surg Oncol 18:2042–2047
Troyan SL, Kinzard V, Gibbs-Strauss SL et al (2009) The FLARE intraoperative near-infrared fluorescence imaging system: a first-in-human clinical trial in breast cancer sentinel lymph node mapping. Ann Surg Oncol 16:2943–2952
Mieog JS, Troyan SL, Hutteman M et al (2011) Towards optimization of imaging system and lymphatic tracer for near-infrared fluorescent sentinel lymph node mapping in breast cancer. Ann Surg Oncol 18:2483–2491
van der Vorst JR, Schaafsma BE, Verbeek FP et al (2013) Dose optimization for near-infrared fluorescence sentinel lymph node mapping in patients with melanoma. Br J Dermatol 168:93–98
Proulx ST, Luciani P, Derzsi S et al (2010) Quantitative imaging of lymphatic function with liposomal indocyanine green. Cancer Res 70:7053–7062
Bahmani B, Gupta S, Upadhyayula S et al (2011) Effect of polyethylene glycol coatings on uptake of indocyanine green loaded nanocapsules by human spleen macrophages in vitro. J Biomed Opt 16:051303
Sugie T (2010) Controversy of axillary diagnosis and treatment. In: Toi M, Winer EP (eds) Local and systemic management of primary breast cancers. Kyoto University Press, Kyoto, pp 61–71
Kitai T, Kawashima M (2012) Transcutaneous detection and direct approach to the sentinel node using axillary compression technique in ICG fluorescence-navigated sentinel node biopsy for breast cancer. Breast Cancer 19:343–348
Sugie T, Kassim KA, Takeuchi M et al (2010) A novel method for sentinel lymph node biopsy by indocyanine green fluorescence technique in breast cancer. Cancers 2:713–720
Abe H, Mori T, Umeda T et al (2011) Indocyanine green fluorescence imaging system for sentinel lymph node biopsies in early breast cancer patients. Surg Today 41:197–202
Tagaya N, Yamazaki R, Nakagawa A et al (2008) Intraoperative identification of sentinel lymph node by near-infrared fluorescence imaging in patients with breast cancer. Am J Surg 195:850–853
Takeuchi M, Sugie T, Abdelazeem K et al (2012) Lymphatic mapping with fluorescence navigation using indocyanine green and axillary surgery in patients with primary breast cancer. Breast J 18:535–541
Aoyama K, Kamio T, Ohchi T et al (2011) Sentinel lymph node biopsy for breast cancer patients using fluorescence navigation with indocyanine green. World J Surg Oncol 9:157
Hirano A, Kamimura M, Ogura K et al (2012) A comparison of indocyanine green fluorescence imaging plus blue dye and blue dye alone for sentinel node navigation surgery in breast cancer patients. Ann Surg Oncol 19:4112–4116
Inoue T, Nishi T, Nakano Y et al (2014) Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer. Breast Cancer. doi:10.1007/s12282-014-0573-8
Sugie T, Sawada T, Tagaya N et al (2013) Comparison of the indocyanine green fluorescence and blue dye methods in detection of sentinel lymph nodes in early-stage breast cancer. Ann Surg Oncol 20:2213–2218
Ahmed M, Purushotham AD, Douek M (2014) Novel techniques for sentinel lymph node biopsy in breast cancer: a systematic review. Lancet Oncol 15:e351–e362
van der Vorst JR, Schaafsma BE, Verbeek FP et al (2012) Randomized comparison of near-infrared fluorescence imaging using indocyanine green and 99(m)technetium with or without patent blue for the sentinel lymph node procedure in breast cancer patients. Ann Surg Oncol 19:4104–4111
Murawa D, Hirche C, Dresel S, Hünerbein M (2009) Sentinel lymph node biopsy in breast cancer guided by indocyanine green fluorescence. Br J Surg 96:1289–1294
Wishart GC, Loh SW, Jones L, Benson JR (2012) A feasibility study (ICG-10) of indocyanine green (ICG) fluorescence mapping for sentinel lymph node detection in early breast cancer. Eur J Surg Oncol 38:651–656
Schaafsma BE, Verbeek FP, Riebergen DD et al (2013) Clinical trial of combined radio-and fluorescence-guided sentinel lymph node biopsy in breast cancer. Br J Surg 100:137–144
Verbeek FP, Troyan SL, Mieog JS et al (2014) Near-infrared fluorescence sentinel lymph node mapping in breast cancer: a multicenter experience. Breast Cancer Res Treat 143:333–342
Sugie T, Kinoshita T, Masuda N et al (2016) Evaluation of the clinical utility of the ICG fluorescence method compared with the radioisotope method for sentinel lymph node biopsy in breast cancer. Ann Surg Oncol 23:44–50
Kelly AM, Dwamena B, Cronin P, Carios RC (2009) Breast cancer sentinel node identification and classification after neoadjuvant chemotherapy-systematic review and meta analysis. Acad Radiol 16:551–563
van Deurzen CH, Vriens BE, Tjan-Heijnen VC et al (2009) Accuracy of sentinel node biopsy after neoadjuvant chemotherapy in breast cancer patients: a systematic review. Eur J Cancer 45:3124–3130
Lyman GH, Temin S, Edge SB et al (2014) Practice. Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 32:1365–1383
Kuehn T, Bauerfeind I, Fehm T et al (2014) Sentinel-lymph node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicenter cohort study. Lancet Oncol 14:609–618
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Japan
About this chapter
Cite this chapter
Sugie, T., Inamoto, T. (2016). Lymphatic Mapping and Optimization of Sentinel Lymph Node Dissection. In: Toi, M., Winer, E., Benson, J., Klimberg, S. (eds) Personalized Treatment of Breast Cancer. Springer, Tokyo. https://doi.org/10.1007/978-4-431-55552-0_9
Download citation
DOI: https://doi.org/10.1007/978-4-431-55552-0_9
Published:
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-55551-3
Online ISBN: 978-4-431-55552-0
eBook Packages: MedicineMedicine (R0)